http://www.legislation.gov.uk/uksi/2004/1031/signature/2019-12-02
The Medicines for Human Use (Clinical Trials) Regulations 2004
text
text/xml
en
MEDICINES
Statute Law Database
2024-06-19
Expert Participation
2019-12-02
These Regulations implement Directive 2001/20/EC on the approximation of laws, regulations and administrative provisions of the Member States relating to the implementation of good clinical practice in the conduct of clinical trials on medicinal products for human use (“the Directive”).
The Medicines for Human Use (Clinical Trials) Regulations 2004
reg. 2(1)
The Medicines for Human Use (Clinical Trials) (Amendment) (EU Exit) Regulations 2019
reg. 3(7)
reg. 1
The Medicines for Human Use (Clinical Trials) Regulations 2004
reg. 2(1)
The Medicines for Human Use (Clinical Trials) (Amendment) (EU Exit) Regulations 2019
reg. 3(9)
reg. 1
The Medicines for Human Use (Clinical Trials) Regulations 2004
reg. 13(4)
The Medicines for Human Use (Clinical Trials) (Amendment) (EU Exit) Regulations 2019
reg. 7(5)(i)
reg. 1
The Medicines for Human Use (Clinical Trials) Regulations 2004
reg. 13(4)
The Medicines for Human Use (Clinical Trials) (Amendment) (EU Exit) Regulations 2019
reg. 7(5)(ii)
reg. 1
The Medicines for Human Use (Clinical Trials) Regulations 2004
reg. 36(2)
The Medicines for Human Use (Clinical Trials) (Amendment) (EU Exit) Regulations 2019
reg. 17
reg. 1
The Medicines for Human Use (Clinical Trials) Regulations 2004
reg. 43(2)-(2F)
The Medicines for Human Use (Clinical Trials) (Amendment) (EU Exit) Regulations 2019
reg. 18
reg. 1
The Medicines for Human Use (Clinical Trials) Regulations 2004
reg. 45(1)(f)(i)
The Medicines for Human Use (Clinical Trials) (Amendment) (EU Exit) Regulations 2019
reg. 20
reg. 1
The Medicines for Human Use (Clinical Trials) Regulations 2004
Sch. 3 Pt. 2
para. 7
The Medicines for Human Use (Clinical Trials) (Amendment) (EU Exit) Regulations 2019
reg. 24(3)(c)(i)
reg. 1
The Medicines for Human Use (Clinical Trials) Regulations 2004
Sch. 3 Pt. 2
para. 7
The Medicines for Human Use (Clinical Trials) (Amendment) (EU Exit) Regulations 2019
reg. 24(3)(c)(ii)
reg. 1
The Medicines for Human Use (Clinical Trials) Regulations 2004
Sch. 3 Pt. 2
para. 8(1)
The Medicines for Human Use (Clinical Trials) (Amendment) (EU Exit) Regulations 2019
reg. 24(3)(d)(i)
reg. 1
The Medicines for Human Use (Clinical Trials) Regulations 2004
Sch. 3 Pt. 2
para. 8(2)
The Medicines for Human Use (Clinical Trials) (Amendment) (EU Exit) Regulations 2019
reg. 24(3)(d)(ii)(aa)
reg. 1
The Medicines for Human Use (Clinical Trials) Regulations 2004
Sch. 3 Pt. 2
para. 8(2)
The Medicines for Human Use (Clinical Trials) (Amendment) (EU Exit) Regulations 2019
reg. 24(3)(d)(ii)(bb)
reg. 1
The Medicines for Human Use (Clinical Trials) Regulations 2004
Sch. 3 Pt. 2
para. 8(2)
The Medicines for Human Use (Clinical Trials) (Amendment) (EU Exit) Regulations 2019
reg. 24(3)(d)(ii)(cc)
reg. 1
The Medicines for Human Use (Clinical Trials) Regulations 2004
Sch. 3 Pt. 2
para. 8(2)(a)
The Medicines for Human Use (Clinical Trials) (Amendment) (EU Exit) Regulations 2019
reg. 24(3)(d)(ii)(dd)
reg. 1
The Medicines for Human Use (Clinical Trials) Regulations 2004
Sch. 7
Pt. 1
The Medicines for Human Use (Clinical Trials) (Amendment) (EU Exit) Regulations 2019
reg. 25
reg. 1
The Medicines for Human Use (Clinical Trials) Regulations 2004
reg. 2(1)
The Anaesthesia Associates and Physician Associates Order 2024
Sch. 5
para. 11(a)
art. 1(3)
The Medicines for Human Use (Clinical Trials) Regulations 2004
reg. 2(1)
The Anaesthesia Associates and Physician Associates Order 2024
Sch. 5
para. 11(b)
art. 1(3)
Signed by authority of the Secretary of State for Health
WarnerParliamentary Under Secretary of State,Department of Health